Close

The New Nebula® Multimode Reader from Lonza Streamlines Quantitative Endotoxin Detection

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

Pharma Leaders to Examine What Comes After AI Pilots at Digital Pharma Advances 2027

The 15th Annual Digital Pharma Advances Conference will bring...

Oliver Healthcare Packaging Highlights Material Selection for Pharmaceutical Drug Protection

Pharmaceutical packaging plays a critical role in protecting medicines...

Thermo Fisher Scientific Introduces E-Gel Power Snap Lite System for Simplified Gel Electrophoresis

Thermo Fisher Scientific has expanded its Invitrogen™ E-Gel™ electrophoresis...
- Advertisement -

Lonza has launched the Nebula® Multimode Reader, the first multimode reader qualified for use with Lonza’s turbidimetric, chromogenic and recombinant endotoxin detection methods. Users can now directly compare results from absorbance-based and fluorescence-based endotoxin assays in one reader, reducing the variables and training required for endotoxin detection. Powered by WinKQCL® Software, the reader also streamlines maintenance and validation procedures with a single data management system while maintaining data integrity compliance. This multimode reader expands Lonza’s Complete Testing Solutions, helping customers increase the efficiency of their endotoxin testing program.


Designed to meet the demands of current QC labs, the Nebula® Multimode Reader provides users with a single solution for use with multiple endotoxin assay types. Its customized plate movement technology and tunable wavelength capability allow users the choice of the turbidimetric, chromogenic or recombinant Factor C methods. As a result, the selection of the best-suited assay for specific samples will be significantly easier.

Full integration of the Nebula® Multimode Reader with Lonza’s WinKQCL® Endotoxin Detection and Analysis Software means data integrity compliance is more easily maintained. The audit trail, trends analysis and other key features from the WinKQCL® Software are available from one instrument, allowing users to realize a reduction in the time and documentation required to validate new test methods.

Janet Yancey-Wrona, Head of Marketing for Testing Solutions, Lonza, commented: “The flexibility that the Nebula® Multimode Reader provides in a single, compact unit will help ease the workload and minimize space consumed in the QC lab. Developed to work with all of Lonza’s quantitative endotoxin tests, the new reader enables our customers to evaluate and compare results more easily when adopting new test methods. We look forward to supporting our customers as they implement this new technology and improve the efficiency of their endotoxin testing programs.”

Employing a single reader that can accommodate multiple testing types means that end-user training, system maintenance, and software analysis are significantly simplified. Laboratories that need to test multiple sample types or validate new testing methods can benefit from more streamlined workflows and greater testing flexibility.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Latest stories

Related stories

Pharma Leaders to Examine What Comes After AI Pilots at Digital Pharma Advances 2027

The 15th Annual Digital Pharma Advances Conference will bring...

Oliver Healthcare Packaging Highlights Material Selection for Pharmaceutical Drug Protection

Pharmaceutical packaging plays a critical role in protecting medicines...

Thermo Fisher Scientific Introduces E-Gel Power Snap Lite System for Simplified Gel Electrophoresis

Thermo Fisher Scientific has expanded its Invitrogen™ E-Gel™ electrophoresis...

UCB Reports New EADV Data on Bimekizumab Treatment in HS

UCB has announced new three-year data for bimekizumab in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »